Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

CI vs UNH

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CI
Cigna Corporation

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$72.68B
5Y Perf.+39.7%
UNH
UnitedHealth Group Incorporated

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$330.28B
5Y Perf.+19.4%

CI vs UNH — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CI logoCI
UNH logoUNH
IndustryMedical - Healthcare PlansMedical - Healthcare Plans
Market Cap$72.68B$330.28B
Revenue (TTM)$277.94B$449.71B
Net Income (TTM)$6.29B$12.04B
Gross Margin9.3%18.8%
Operating Margin3.4%4.2%
Forward P/E9.1x19.9x
Total Debt$31.46B$78.39B
Cash & Equiv.$7.68B$24.36B

CI vs UNHLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CI
UNH
StockMay 20May 26Return
Cigna Corporation (CI)100139.7+39.7%
UnitedHealth Group … (UNH)100119.4+19.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: CI vs UNH

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: UNH leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Cigna Corporation is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
CI
Cigna Corporation
The Insurance Pick

CI is the clearest fit if your priority is growth exposure and sleep-well-at-night.

  • Rev growth 11.3%, EPS growth 82.9%, 3Y rev CAGR 15.1%
  • Lower volatility, beta 0.35, Low D/E 75.1%, current ratio 0.85x
  • Beta 0.35, yield 2.2%, current ratio 0.85x
Best for: growth exposure and sleep-well-at-night
UNH
UnitedHealth Group Incorporated
The Insurance Pick

UNH carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 25 yrs, beta 0.59, yield 2.4%
  • 217.0% 10Y total return vs CI's 124.1%
  • 11.8% revenue growth vs CI's 11.3%
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthUNH logoUNH11.8% revenue growth vs CI's 11.3%
ValueCI logoCILower P/E (9.1x vs 19.9x)
Quality / MarginsUNH logoUNHCombined ratio 1.0 vs CI's 1.0 (lower = better underwriting)
Stability / SafetyCI logoCIBeta 0.35 vs UNH's 0.59, lower leverage
DividendsUNH logoUNH2.4% yield, 25-year raise streak, vs CI's 2.2%
Momentum (1Y)UNH logoUNH-7.9% vs CI's -15.4%
Efficiency (ROA)CI logoCI4.1% ROA vs UNH's 3.9%, ROIC 10.4% vs 9.2%

CI vs UNH — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CICigna Corporation
FY 2025
Evernorth
83.2%$235.0B
Cigna Healthcare
16.8%$47.4B
UNHUnitedHealth Group Incorporated
FY 2025
Unitedhealthcare
94.4%$332.4B
Optumhealth
5.6%$19.8B

CI vs UNH — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCILAGGINGUNH

Income & Cash Flow (Last 12 Months)

UNH leads this category, winning 4 of 6 comparable metrics.

UNH is the larger business by revenue, generating $449.7B annually — 1.6x CI's $277.9B. Profitability is closely matched — net margins range from 2.7% (UNH) to 2.3% (CI).

MetricCI logoCICigna CorporationUNH logoUNHUnitedHealth Grou…
RevenueTrailing 12 months$277.9B$449.7B
EBITDAEarnings before interest/tax$12.1B$23.2B
Net IncomeAfter-tax profit$6.3B$12.0B
Free Cash FlowCash after capex$7.7B$19.7B
Gross MarginGross profit ÷ Revenue+9.3%+18.8%
Operating MarginEBIT ÷ Revenue+3.4%+4.2%
Net MarginNet income ÷ Revenue+2.3%+2.7%
FCF MarginFCF ÷ Revenue+2.8%+4.4%
Rev. Growth (YoY)Latest quarter vs prior year+4.6%+2.0%
EPS Growth (YoY)Latest quarter vs prior year+29.1%+0.7%
UNH leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

CI leads this category, winning 6 of 6 comparable metrics.

At 12.4x trailing earnings, CI trades at a 55% valuation discount to UNH's 27.5x P/E. On an enterprise value basis, CI's 8.2x EV/EBITDA is more attractive than UNH's 16.5x.

MetricCI logoCICigna CorporationUNH logoUNHUnitedHealth Grou…
Market CapShares × price$72.7B$330.3B
Enterprise ValueMkt cap + debt − cash$96.5B$384.3B
Trailing P/EPrice ÷ TTM EPS12.43x27.50x
Forward P/EPrice ÷ next-FY EPS est.9.09x19.87x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple8.20x16.48x
Price / SalesMarket cap ÷ Revenue0.26x0.74x
Price / BookPrice ÷ Book value/share1.75x3.26x
Price / FCFMarket cap ÷ FCF8.66x20.55x
CI leads this category, winning 6 of 6 comparable metrics.

Profitability & Efficiency

CI leads this category, winning 8 of 9 comparable metrics.

CI delivers a 15.1% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $12 for UNH. CI carries lower financial leverage with a 0.75x debt-to-equity ratio, signaling a more conservative balance sheet compared to UNH's 0.77x. On the Piotroski fundamental quality scale (0–9), CI scores 8/9 vs UNH's 6/9, reflecting strong financial health.

MetricCI logoCICigna CorporationUNH logoUNHUnitedHealth Grou…
ROE (TTM)Return on equity+15.1%+11.5%
ROA (TTM)Return on assets+4.1%+3.9%
ROICReturn on invested capital+10.4%+9.2%
ROCEReturn on capital employed+9.2%+9.7%
Piotroski ScoreFundamental quality 0–986
Debt / EquityFinancial leverage0.75x0.77x
Net DebtTotal debt minus cash$23.8B$54.0B
Cash & Equiv.Liquid assets$7.7B$24.4B
Total DebtShort + long-term debt$31.5B$78.4B
Interest CoverageEBIT ÷ Interest expense6.77x4.71x
CI leads this category, winning 8 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — CI and UNH each lead in 3 of 6 comparable metrics.

A $10,000 investment in CI five years ago would be worth $11,658 today (with dividends reinvested), compared to $9,722 for UNH. Over the past 12 months, UNH leads with a -7.9% total return vs CI's -15.4%. The 3-year compound annual growth rate (CAGR) favors CI at 3.9% vs UNH's -7.7% — a key indicator of consistent wealth creation.

MetricCI logoCICigna CorporationUNH logoUNHUnitedHealth Grou…
YTD ReturnYear-to-date-0.7%+8.8%
1-Year ReturnPast 12 months-15.4%-7.9%
3-Year ReturnCumulative with dividends+12.2%-21.4%
5-Year ReturnCumulative with dividends+16.6%-2.8%
10-Year ReturnCumulative with dividends+124.1%+217.0%
CAGR (3Y)Annualised 3-year return+3.9%-7.7%
Evenly matched — CI and UNH each lead in 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CI and UNH each lead in 1 of 2 comparable metrics.

CI is the less volatile stock with a 0.35 beta — it tends to amplify market swings less than UNH's 0.59 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UNH currently trades 88.8% from its 52-week high vs CI's 81.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCI logoCICigna CorporationUNH logoUNHUnitedHealth Grou…
Beta (5Y)Sensitivity to S&P 5000.35x0.59x
52-Week HighHighest price in past year$338.89$409.70
52-Week LowLowest price in past year$239.51$234.60
% of 52W HighCurrent price vs 52-week peak+81.3%+88.8%
RSI (14)Momentum oscillator 0–10051.283.3
Avg Volume (50D)Average daily shares traded1.6M8.1M
Evenly matched — CI and UNH each lead in 1 of 2 comparable metrics.

Analyst Outlook

UNH leads this category, winning 2 of 2 comparable metrics.

Wall Street rates CI as "Buy" and UNH as "Buy". Consensus price targets imply 19.0% upside for CI (target: $328) vs 5.9% for UNH (target: $385). For income investors, UNH offers the higher dividend yield at 2.39% vs CI's 2.20%.

MetricCI logoCICigna CorporationUNH logoUNHUnitedHealth Grou…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$328.00$385.43
# AnalystsCovering analysts3952
Dividend YieldAnnual dividend ÷ price+2.2%+2.4%
Dividend StreakConsecutive years of raises625
Dividend / ShareAnnual DPS$6.06$8.70
Buyback YieldShare repurchases ÷ mkt cap+5.0%+1.7%
UNH leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

UNH leads in 2 of 6 categories (Income & Cash Flow, Analyst Outlook). CI leads in 2 (Valuation Metrics, Profitability & Efficiency). 2 tied.

Best OverallCigna Corporation (CI)Leads 2 of 6 categories
Loading custom metrics...

CI vs UNH: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is CI or UNH a better buy right now?

For growth investors, UnitedHealth Group Incorporated (UNH) is the stronger pick with 11.

8% revenue growth year-over-year, versus 11. 3% for Cigna Corporation (CI). Cigna Corporation (CI) offers the better valuation at 12. 4x trailing P/E (9. 1x forward), making it the more compelling value choice. Analysts rate Cigna Corporation (CI) a "Buy" — based on 39 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CI or UNH?

On trailing P/E, Cigna Corporation (CI) is the cheapest at 12.

4x versus UnitedHealth Group Incorporated at 27. 5x. On forward P/E, Cigna Corporation is actually cheaper at 9. 1x.

03

Which is the better long-term investment — CI or UNH?

Over the past 5 years, Cigna Corporation (CI) delivered a total return of +16.

6%, compared to -2. 8% for UnitedHealth Group Incorporated (UNH). Over 10 years, the gap is even starker: UNH returned +217. 0% versus CI's +124. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CI or UNH?

By beta (market sensitivity over 5 years), Cigna Corporation (CI) is the lower-risk stock at 0.

35β versus UnitedHealth Group Incorporated's 0. 59β — meaning UNH is approximately 65% more volatile than CI relative to the S&P 500. On balance sheet safety, Cigna Corporation (CI) carries a lower debt/equity ratio of 75% versus 77% for UnitedHealth Group Incorporated — giving it more financial flexibility in a downturn.

05

Which is growing faster — CI or UNH?

By revenue growth (latest reported year), UnitedHealth Group Incorporated (UNH) is pulling ahead at 11.

8% versus 11. 3% for Cigna Corporation (CI). On earnings-per-share growth, the picture is similar: Cigna Corporation grew EPS 82. 9% year-over-year, compared to -14. 7% for UnitedHealth Group Incorporated. Over a 3-year CAGR, CI leads at 15. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CI or UNH?

UnitedHealth Group Incorporated (UNH) is the more profitable company, earning 2.

7% net margin versus 2. 2% for Cigna Corporation — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4. 2% versus 3. 3% for CI. At the gross margin level — before operating expenses — UNH leads at 18. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CI or UNH more undervalued right now?

On forward earnings alone, Cigna Corporation (CI) trades at 9.

1x forward P/E versus 19. 9x for UnitedHealth Group Incorporated — 10. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CI: 19. 0% to $328. 00.

08

Which pays a better dividend — CI or UNH?

All stocks in this comparison pay dividends.

UnitedHealth Group Incorporated (UNH) offers the highest yield at 2. 4%, versus 2. 2% for Cigna Corporation (CI).

09

Is CI or UNH better for a retirement portfolio?

For long-horizon retirement investors, Cigna Corporation (CI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

35), 2. 2% yield, +124. 1% 10Y return). Both have compounded well over 10 years (CI: +124. 1%, UNH: +217. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CI and UNH?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CI is a mid-cap deep-value stock; UNH is a large-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

CI

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Dividend Yield > 0.8%
Run This Screen
Stocks Like

UNH

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Dividend Yield > 0.9%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform CI and UNH on the metrics below

Revenue Growth>
%
(CI: 4.6% · UNH: 2.0%)
Net Margin>
%
(CI: 2.3% · UNH: 2.7%)
P/E Ratio<
x
(CI: 12.4x · UNH: 27.5x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.